glp 1 for sleep apnea insurance Did You Know? The FDA has approved GLP-1 treatments moderate to severe obstructive (OSA) in adults with obesity. This breakthrough provides a new treatment option beyond traditional CPAP therapy The new approval means that

While most major insurers and Medicare plans cover GLP-1s for T2D, coverage for GLP-1s for obesity and weight management is much more limited and often excluded from standard plans

Of that weight loss, approximately 75 percent came from fat mass and 25 percent from lean mass

consult your healthcare provider if symptoms persist or worsen

Weight loss typically slows or plateaus by 1218 months while using a GLP-1

With decreased appetite can come poor nutrition and muscle mass, bone density and hair loss

A systematic review of 12 studies found consistent reductions in binge eating behaviors with liraglutide, semaglutide, and dulaglutide ( White et al., Pharmacotherapy, 2026 )